[1] Pjetursson BE, Asgeirsson AG,Zwahlen M, et al. Improvements in implant dentistry over the last decade:comparison of survivaland complication rates in older and newer publications[J]. Int J Oral Maxillofac Implants, 2014,29(Suppl):308-324.
[2] Derks J, Tomasi C. Peri-implant health and disease:a systematic review of current epidemiology[J]. J Clin Periodontol, 2015, 42(Suppl 16):S158-S171.
[3] Lindhe J, Meyle J. Peri-implant diseases:consensus report of the sixth european workshop on periodontology[J]. J Clin Periodontol,2008, 35(8 Suppl):282-285.
[4] Graetz C, El-Sayed KF, Geiken A, et al. Effect of periodontitis history on implant success:a long-term evaluation during supportive periodontal therapy in a university setting[J]. Clin Oral Investig, 2018, 22(1):235-244.
[5] 谢也斯,乔敏,徐宝华,等.牙周炎病史和维护情况对种植修复预后的影响[J].中华老年口腔医学杂志,2017,15(4):253-256.
[6] Quaranta A, Assenza B, D'Isidoro O, et al. The impact of smoking and previous periodontal disease on peri-implant microbiota and health:a retrospective study up to 7-year follow-up[J].Ann Stomatol(Roma), 2015,6(1):21-28.
[7] Salvi GE, Bosshardt DD, Lang NP, et al.Temporal sequence of hard and soft tissue healing around titanium dental implants[J].Periodontol,2000,2015,68(1):135-152.
[8] Damgaard C, Holmstrup P, van Dyke TE, et al. The complement system and its role in the pathogenesis of periodontitis:current concepts[J]. J Periodont Res,2015,50(3):283-293.
[9] 杨靖梅,朱彦,周乔,等.补体5a及其受体和效应通路与牙周炎的关系[J].国际口腔医学杂志, 2014, 41(5):603-608.
[10] 李娜,高爱超,王丽丽,等.补体与牙周炎发生发展及其治疗[J].国际口腔医学杂志,2015,42(3):344-347.
[11] Yuan Y, Yan D, Han G, et al. Complement C3 depletion links to the expansion of regulatory T cells and compromises T-cell immunity in human abdominal sepsis:A prospective pilot study[J]. J Crit Care, 2013,28(6):1032-1038.
[12] Yuan Y, Ren J, Cao S, et al. Exogenous C3 protein enhances the adaptive immune response to polymicrobial sepsis through down-regulation of regulatory T cells[J]. Int Immunopharmacol, 2012, 12(1):271-277.
[13] Liang S, Krauss JL, Domon H, et al. The C5a receptor impairs IL-12-dependent clearance of porphyromonas gingivalis and is required for induction of periodontal bone loss[J]. J Immunol,2011,186(2):869-877.
[14] Maekawa T, Abe T, Hajishengallis E, et al. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis[J]. J Immunol,2014,192(12):6020-6027.
[15] Hajishengallis G, Lambris JD. Complement and dysbiosis in periodontal disease[J]. Immunobiology,2012,217(11):1111-1116.
[16] Belstrøm D, Holmstrup P, Damgaard C, et al. The atherogenic bacterium porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes[J]. Infect Immun, 2011,79(4):1559-1565.
[17] Potempa M, Potempa J, Kantyka T, et al. Interpain A, a cysteine proteinase from prevotella intermedia, inhibits complement by degrading complement factor C3[J]. PLoS Pathog,2009, 5(2):e1000316.
[18] Malm S, Jusko M, Eick S, et al. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia[J].PLoS One,2012,7(4):e34852.
[19] Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement[J]. Cell Host Microbe,2011,10(5):497-506.
[20] McDowell JV, Huang B, Fenno JC,et al. Analysis of a unique interaction between the complement regulatory protein factor H and the periodontal pathogen treponema denticola[J]. Infect Immun, 2009,77(4):1417-1425.
[21] Asakawa R, Komatsuzawa H, Kawai T,et al. Outer membrane protein 100, a versatile virulence factor of actinobacillus actinomycetemcomitans[J]. Mol Microbiol,2003,50(4):1125-1139.
[22] Jusko M, Potempa J, Karim AY,et al.A metalloproteinase karilysin present in the majority of tannerella forsythia isolates inhibits all pathways of the complement system[J].J Immunol,2012,188(5):2338-2349.
[23] Verardi S, Quaranta M, Bordin S. Peri-implantitis fibroblasts respond to host immune factor C1q[J]. J Periodont Res, 2011, 46(1):134-140.
[24] Mahtout H, Curt S, Chandad F, et al. Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells[J]. FEMS Immunol Med Microbiol, 2011, 62(3):295-303.
[25] Ignatius A, Ehrnthaller C, Brenner RE, et al. The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro[J]. J Trauma,2011,71(4):952-960.
[26] Huber-Lang M, Kovtun A, Ignatius A. The role of complement in trauma and fracture healing[J]. Semin Immunol,2013,25(1):73-78.
[27] Schraufstatter IU, Discipio RG, Zhao M, et al. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation[J]. J Immunol,2009,182(6):3827-3836.
[28] Ignatius A, Schoengraf P, Kreja L, et al. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β[J]. J Cell Biochem, 2011,112(9):2594-2605.
[29] Ehrnthaller C, Huber-Lang M, Nilsson P, et al. Complement C3 and C5 deficiency affects fracture healing[J]. PLoS One,2013,8(11):e81341.
[30] Schoengraf P, Lambris JD, Recknagel S, et al. Does complement play a role in bone development and regeneration[J]. Immunobiology,2013,218(1):1-9.
[31] Matsuoka K, Park K, Ito M, et al. Osteoclast-derived complement component 3a stimulates osteoblast differentiation[J]. J Bone Miner Res, 2014,29(7):1522-1530.
[32] Tu Z, Bu H, Dennis JE, et al. Efficient osteoclast differentiation requires local complement activation[J].Blood,2010,116(22):4456-4463.
[33] Trindade R, Albrektsson T, Tengvall P, et al. Foreign body reaction to biomaterials:on mechanisms for buildup and breakdown of osseointegration[J]. Clin Implant Dent R, 2016, 18(1):192-203.
[34] Romero-Gavilán F, Gomes NC, Ródenas J, et al. Proteome analysis of human serum proteins adsorbed onto different titanium surfaces used in dental implants[J]. Biofouling, 2017, 33(1):98-111.
[35] Trindade R, Albrektsson T, Galli S, et al. Osseointegration and foreign body reaction:Titanium implants activate the immune system and suppress bone resorption during the first 4 weeks after implantation[J]. Clin Implant Dent Relat Res, 2018, 20(1):82-91.
[36] Romero-Gavilan F, Araújo-Gomes N, Sánchez-Pérez AM, et al. Bioactive potential of silica coatings and its effect on the adhesion of proteins to titanium implants[J]. Colloid Surf B Biointerfaces, 2018, 162:316-325.
[37] Andersson J, Bexborn F, Klinth J, et al. Surface-attached PEO in the form of activated pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model[J]. J Biomed Mater Res A, 2006,76(1):25-34.
[38] Narayanan R, Kuppermann BD. Corticosteroids and anti-complement therapy in retinal diseases[J]. Handb Exp Pharmacol, 2017,242:309-320.
[39] Abe T, Hosur KB, Hajishengallis E, et al.Local complement-targeted intervention in periodontitis:proof-of-concept using a C5a receptor (CD88) antagonist[J]. J Immunol,2012,189(11):5442-5448. |
